2009
DOI: 10.1128/jvi.00620-09
|View full text |Cite
|
Sign up to set email alerts
|

The Transmembrane Domain of BST-2 Determines Its Sensitivity to Down-Modulation by Human Immunodeficiency Virus Type 1 Vpu

Abstract: Bone marrow stromal cell antigen 2 (BST-2, also known as tetherin) restricts the production of a number of enveloped viruses by blocking virus release from the cell surface. This antiviral activity is counteracted by such viral factors as Vpu of human immunodeficiency virus type 1 (HIV-1). Here, we report that Vpu antagonizes human BST-2 but not BST-2 derived from African green monkeys. The determinants of susceptibility to Vpu map to the transmembrane domain of BST-2. In accordance with this, expression of hu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

28
158
2

Year Published

2010
2010
2015
2015

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 109 publications
(188 citation statements)
references
References 30 publications
28
158
2
Order By: Relevance
“…The cytoplasmic tail is involved in AP-2-dependent endocytosis of the molecule (28,43), while the transmembrane domain provides specificity for interaction with and downregulation by Vpu (11,12,23,24,30). Disulfide-linked dimerization of tetherin is required for restriction (28).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The cytoplasmic tail is involved in AP-2-dependent endocytosis of the molecule (28,43), while the transmembrane domain provides specificity for interaction with and downregulation by Vpu (11,12,23,24,30). Disulfide-linked dimerization of tetherin is required for restriction (28).…”
Section: Discussionmentioning
confidence: 99%
“…Vpu leads to surface downregulation and proteasomal degradation of CD4 in infected T cells and macrophages (23,34,40,41) and enhances viral particle release in restrictive cell types (16,38). Vpu overcomes tetherin-mediated restriction via an interaction facilitated through their respective transmembrane (TM) domains (12,13,24,30). The potential mechanisms accounting for tetherin surface downregulation by Vpu include proteasomal and lysosomal degradation together with sequestration of tetherin within the transGolgi network (TGN) (5).…”
mentioning
confidence: 99%
“…39,40 Sequence variations in the TM domain of tetherin that affect sensitivity to Vpu have been identified. 41,42 Formation of Vpu/tetherin hetero-oligomers through direct interactions between their TM domains may therefore be essential for Vpu function, and these hetero-oligomers may be structurally related to Vpu homo-oligomers. A proposed therapeutic strategy is to use ''decoy'' peptides to sequester Vpu through formation of unproductive hetero-oligomers, allowing tetherin to inhibit viral release from infected cells even in the presence of Vpu.…”
Section: Introductionmentioning
confidence: 99%
“…After IFN-g treatment, a 3-fold increase in mRNA and greater than 2-fold increase in protein were observed. Induction of tetherin by IFNs in non-neuronal cells has been studied by many authors in different cell types and concluded to be cell type-dependant (Neil et al, 2007;Van Damme et al, 2008;Miyagi et al, 2009;Rong et al, 2009).…”
Section: Discussionmentioning
confidence: 99%